U.S. Healthcare Services Stock News

Everest Group (EG) stock has been moving on the back of company fundamentals, including disciplined underwriting, specialty business growth, higher investment income and active capital management that includes dividends and share repurchases. See our latest analysis for Everest Group. Everest Group’s share price has eased in the very short term, with a 1-day share price return that declined 2.08% and a 7-day share price return that declined 1.93%. However, the 30-day share price return of...

Johnson & Johnson (NYSE:JNJ) has surpassed the $100b annual revenue mark for the first time in its 140 year history, supported by strong second quarter results. The company raised its guidance for 2026, signaling confidence in its longer term revenue outlook. MedTech unit DePuy Synthes agreed to acquire Expanding Innovations, Inc. to expand Johnson & Johnson’s presence in advanced spine surgery technology. For investors watching Johnson & Johnson, the $100b revenue milestone arrives with a...

Nexstar Media Group (NXST) is back in focus after The Hill, its political news outlet, launched The Hill Insider, a premium two tier digital subscription offering that layers membership revenue on top of existing advertising. See our latest analysis for Nexstar Media Group. Nexstar Media Group’s latest product moves come as the stock shows mixed momentum, with a 1 month share price return of 6.33% but a 90 day share price decline of 7.19%, while the 5 year total shareholder return of 49.04%...

After a huge 1 year gain for Teradyne stock, the valuation picture is more finely balanced, with recent pullbacks, a low overall value score and market multiples that look closer to about right than clearly cheap. Teradyne has returned 272.9% over the past year, which puts the current share price in focus as investors reassess how much future AI related growth is already reflected in the stock. Expectations around Teradyne's role in AI driven semiconductor testing and industrial automation...

Cheniere Energy (NYSE:LNG) has appointed former McKesson CFO Britt Vitalone as an independent director. The move increases the size of Cheniere Energy's board and adds extensive financial and audit experience. Vitalone brings boardroom expertise in capital allocation, transaction oversight, and large company operations. Cheniere Energy is a major US liquefied natural gas exporter, operating at the intersection of global energy demand and long term LNG supply contracts. The addition of Britt...

Walt Disney stock is back in focus after a difficult stretch, with shares down 43.4% over five years, while both a Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently suggest the stock may be trading below what the underlying business could justify. The share price has fallen 43.4% over the past five years, which raises the question of whether investor expectations have swung too far toward pessimism. On the upside, efforts to refine the streaming strategy and...

Take-Two Interactive Software (TTWO) is back in focus after a recent share price decline and a Zacks Rank of #4 (Sell), as analysts trim earnings estimates ahead of the August 7, 2026 report. See our latest analysis for Take-Two Interactive Software. Take-Two Interactive Software’s recent pullback comes after analysts cut earnings expectations. However, the stock still shows a 12.75% 1 month share price return and a 60.38% 3 year total shareholder return, which may indicate that longer term...

AngloGold Ashanti (AU) has secured a US$500 million financing facility from Nedbank CIB for its Geita Gold Mine, a key development intended to extend the mine’s life and support higher production levels. See our latest analysis for AngloGold Ashanti. At a share price of US$79.14, AngloGold Ashanti has seen its short term share price momentum fade, with the 30 day share price return down 14.25% and the 90 day share price return down 24.07%. However, the 1 year total shareholder return of...

NextDecade stock has delivered a strong 119.3% return over the past five years, yet its low value score suggests the current share price of US$7.61 may not stand out as a clear bargain based on broader valuation checks. Over five years, NextDecade has returned 119.3%, which puts the recent volatility into the context of a longer term upswing for existing holders. The planned Rio Grande LNG project, which aims to position NextDecade as a major US LNG exporter, can support investor...

IQVIA Holdings (IQV) has recently drawn investor attention after fresh performance data showed double digit gains over the past month and past 3 months, alongside mixed longer term total returns and ongoing revenue and net income growth. See our latest analysis for IQVIA Holdings. Over the past year, IQVIA Holdings has paired a 30.36% 1 year total shareholder return with a 1 month share price return of 15.93% and a 3 month share price return of 20.27%. However, longer 3 and 5 year total...

The FDA’s decision to lift clinical holds on Intellia Therapeutics (NTLA)’s MAGNITUDE and MAGNITUDE-2 trials has refocused attention on the stock, as patient enrollment for its in vivo CRISPR programs can now continue. See our latest analysis for Intellia Therapeutics. Despite the regulatory relief, Intellia Therapeutics’ 1-day share price return declined 1.95% to US$13.04, extending a 7-day share price decline of 22.57%. However, the year to date share price return of 41.59% contrasts with a...

In recent days, Affirm Holdings reported quarterly revenue of US$1.04 billion and net profit of US$102.9 million, while Bed Bath & Beyond enabled Affirm installments across its brands. This combination of improving profitability, fresh merchant adoption and ongoing debate over leverage and capital efficiency has sharpened focus on Affirm’s business quality. We’ll now examine how Affirm’s move into Bed Bath & Beyond’s checkout, alongside profitability gains, influences its existing...

Doximity (DOCS) is back in focus after reporting that its HIPAA compliant clinical AI tool, Doximity Ask, ranked first for safety in the independent NOHARM benchmark run by Stanford and Harvard physicians. See our latest analysis for Doximity. Doximity’s share price has shown a short burst of strength, with a 1 month share price return of 7.64% and a 7 day share price return of 2.63%. However, this follows a much weaker period where the year to date share price return is down 48.58% and the 1...

Over the last 7 days, the United States market has remained flat, but in the past 12 months, it has risen by an impressive 21%, with earnings forecast to grow by 18% annually. In such a climate, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to capitalize on future growth.

Over the last 7 days, the United States market has remained flat, yet it is up 21% over the past year with earnings forecasted to grow by 18% annually. In this context of growth and stability, identifying companies with high insider ownership can be a promising strategy as it often indicates confidence from those closest to the company’s operations.

In the last week, the market has been flat, though it is up 21% over the past year with earnings expected to grow by 18% per annum in the coming years. Investing in penny stocks—often associated with smaller or newer companies—can still open doors to growth opportunities when these stocks are supported by strong financial health. We'll explore several penny stocks that stand out for their financial strength and potential for long-term success.

In recent days, AAON has drawn attention as analysts highlight a potential valuation gap between its discounted cash flow estimates and traditional earnings-based metrics, while the company continues to recover from earlier ERP-related operational disruptions. At the same time, rapid growth in AAON’s BasX data center cooling business and its expanding partnerships have reinforced the company’s role in supporting technology and infrastructure build-outs. We’ll now explore how AAON’s apparent...

Kimco Realty (KIM) recently priced a $525 million private offering of exchangeable senior notes, slightly above its initial plan, giving investors fresh information to assess ahead of next month’s second quarter earnings release. See our latest analysis for Kimco Realty. The recent exchangeable notes deal comes at a time when Kimco Realty’s share price, now at $25.09, has cooled slightly in the past month but still reflects stronger year to date share price momentum and solid multi year total...

On July 14, 2026, Stephens upgraded Wesco International Inc. to Overweight from Equal-Weight, citing the company’s promising exposure to data centers and utility infrastructure as key drivers of its outlook. The brokerage expects these two areas to approach half of Wesco’s total sales by 2027, underlining how infrastructure tied to digitalization and power networks is becoming central to the company’s business mix. With Wesco’s recent 7-day share price gain and its growing focus on data...

Earlier this week, AST SpaceMobile completed a private offering of US$1.00 billion in 1.625% senior unsecured convertible notes due February 1, 2034, issued under Rule 144A to fund network expansion, additional launches, and potential partnerships or acquisitions. The deal, which includes capped call transactions and a conversion price set at a 20% premium to the recent share price, highlights how AST SpaceMobile is relying on convertible debt to support an increasingly capital-intensive...

AI licensing deal reframes CEVA stock story CEVA (CEVA) has drawn fresh attention after announcing a landmark AI licensing agreement with a major U.S. software and AI platform company focused on custom silicon for next generation intelligent computing devices. The customer selected CEVA's NeuPro-M neural processing unit IP to handle on device generative, multimodal and emerging agentic AI workloads within tight power, area and thermal limits, extending CEVA's reach beyond its traditional...

Palomar Holdings (PLMR) has drawn fresh attention after raising its full-year 2026 net profit guidance and approving a US$200 million share buyback, a combination that directly affects earnings expectations and shareholder returns. See our latest analysis for Palomar Holdings. Despite the updated 2026 guidance and fresh buyback, Palomar Holdings' share price has pulled back recently, with the 7 day share price return down 8.9% and the 1 year total shareholder return down 8.6%, although the 3...

In July 2026, BriaCell Therapeutics Corp. announced it had engaged Charles River Associates and Kaleio, Inc. to support commercial strategy, market access evaluation, and brand planning for Bria-IMT, an investigational metastatic breast cancer therapy currently in a pivotal Phase 3 study and not yet commercially approved. By tapping Charles River Associates to analyze epidemiology, pricing, prescriber dynamics, and US market access potential for Bria-IMT, BriaCell highlighted CRA’s role in...

DorianG (LPG) shares were in focus after the company declared an irregular cash dividend of $1.00 per share, returning about $42.8 million to investors, with payment scheduled for August 12, 2026. See our latest analysis for DorianG. At a share price of $42.03, DorianG has seen a 19.34% 90 day share price return and a 69.82% year to date share price return, alongside a 65.21% 1 year total shareholder return and a 681.12% 5 year total shareholder return. This suggests momentum has been strong...